Quick Answer
ABBOTT LABORATORIES reported Total Assets of $86.71 billion for fiscal year 2025.
ABBOTT LABORATORIES Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $86.71B | +6.5% |
| 2024 | $81.41B | +11.2% |
| 2023 | $73.21B | -1.6% |
| 2022 | $74.44B | -1.0% |
| 2021 | $75.20B | +3.6% |
| 2020 | $72.55B | +6.9% |
| 2019 | $67.89B | +1.1% |
| 2018 | $67.17B | -11.9% |
| 2017 | $76.25B | +44.8% |
| 2016 | $52.67B | +27.7% |
| 2015 | $41.25B | +0.1% |
| 2014 | $41.21B | -4.0% |
| 2013 | $42.94B | -36.1% |
| 2012 | $67.23B | +11.5% |
| 2011 | $60.28B | -0.5% |
| 2010 | $60.57B | +15.2% |
| 2009 | $52.58B | +24.0% |
| 2008 | $42.42B | +6.8% |
| 2007 | $39.71B | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $84.18B | +13.2% | +0.2% |
| June 30, 2025 | $84.00B | +15.0% | +3.1% |
| March 31, 2025 | $81.45B | +12.4% | +0.0% |
| December 31, 2024 | $81.41B | +11.2% | +9.5% |
| September 30, 2024 | $74.36B | +3.1% | +1.8% |
| June 30, 2024 | $73.02B | -0.5% | +0.8% |
| March 31, 2024 | $72.47B | -1.8% | -1.0% |
| December 31, 2023 | $73.21B | -1.6% | +1.6% |
- ABBOTT LABORATORIES showed an increase of +6.5% in Total Assets compared to the prior fiscal year.
- Over the 2007–2025 period, ABBOTT LABORATORIES’s total assets has grown by 118.3% (from $39.71 billion to $86.71 billion).
- The most recent figure is from ABBOTT LABORATORIES’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: